Since December 2019, a new coronavirus disease, COVID-19, has been spreading in China, particularly in the city of Wuhan, Hubei province. Several studies have identified common characteristics of COVID-19-associated pneumonia, including epidemiological, demographic, clinical, laboratory, radiographic, and treatment data^[@bib1]-[@bib5]^. The severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been classified as the β-coronavirus 2b lineage and has characteristics typical of the coronavirus family^[@bib6]^. A recent study demonstrated that SARS-CoV-2 is very similar to another coronavirus carried by bats, leading to speculation that the novel virus may be hosted in bats^[@bib7]^. Current evidence suggests that wild animals illegally traded in the Huanan Seafood Wholesale Market were the likely culprit of the spread of the virus among humans^[@bib8]^.

It is well established that patients with fractures are susceptible to pulmonary infection, especially those with lower-limb fracture and limited ambulatory capacity^[@bib9]^. It has been reported that COVID-19 infections are clustered within groups of individuals in close contact in places such as supermarkets, public transportation, and hospitals^[@bib10]^. Patients with severe fractures often require hospitalization and surgical treatment, making this population susceptible to COVID-19 infection. Thus, the question arises concerning the best medical practices for patients who have both fracture and COVID-19 infection at the time of presentation. There is an urgent need to determine whether patients with fracture who are affected by COVID-19 have a higher risk of mortality because of the infection. The purpose of the present retrospective study was to analyze the clinical data for 10 hospitalized patients with both a fracture and COVID-19 infection and to identify the most appropriate management strategy.

Materials and Methods
=====================

Study Design and Participants
-----------------------------

A retrospective review of the medical records of 10 patients with both a bone fracture and COVID-19 infection was performed. The patients were admitted to Wuhan Union Hospital, Wuhan General Hospital of Guangzhou Military Command, Hubei Hospital of Traditional Chinese Medicine, Dongxihu District People's Hospital of Wuhan City, Wuhan Pu'ai Hospital, Hanyang University Hospital, Taihe Hospital of Shiyan City, and Ezhou Central Hospital between January 1, 2020, and February 27, 2020. COVID-19 was diagnosed in accordance with the New Coronavirus Pneumonia Prevention and Control Program, 6th edition, published by the National Health Commission of China^[@bib11]^. Importantly, to eliminate the potential missed cases of COVID-19, clinical diagnosis was added in the 5th edition of the New Coronavirus Pneumonia Prevention and Control Program, which stipulated that a suspected case with an evident radiological manifestation should be identified as a confirmed case of COVID-19^[@bib12]^. Six of the 10 patients were positive for SARS-CoV-2 on the basis of quantitative reverse transcription polymerase chain reaction (qRT-PCR) of throat swab samples. Of the remaining 4 patients, 3 had a negative result and 1 did not receive the qRT-PCR test during her hospitalization. All patients presented with clear evidence of viral pneumonia on computed tomography (CT) scans. Informed consent was obtained from all participants before enrollment in the study.

Data Collection
---------------

Primary data included clinical characteristics, signs and symptoms, results of laboratory tests, evidence of COVID-19 infection, treatment, and clinical outcome. The medical records were provided by the 8 participating hospitals and were analyzed at the Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, with use of a customized data-collection form. Throat swab samples were obtained from patients who were identified as having a suspected COVID-19 infection and were analyzed by qRT-PCR with use of a kit recommended by the Chinese Center for Disease Control and Prevention (CDC) according to the World Health Organization (WHO) guidelines. Total RNA was extracted from throat swabs with use of the RNA isolation kit (Zhongzhi) and was reverse-transcribed with use of the One Step RT-PCR Kit (Takara). Primers were designed on the basis of the Wuhan-Hu-1 sequence (MN908947) to amplify part of the sequence of the S segment (nt 21730-22458). The primer sequences were 5′-CTCAGGACTTGTTCTTACCTT-3′ and 5′-CAAGTGCACAGTCTACAGC-3′. The clinical outcomes were assessed at the follow-up examination on February 27, 2020.

Statistical Analysis
--------------------

SPSS software (version 23.0; IBM) was used for statistical analysis of primary data. Categorical variables are presented as the median and interquartile range or as the number and percentage. Diagrams of curves were drawn with use of Prism (version 8.3; GraphPad).

Results
=======

The 10 patients (8 women and 2 men) ranged from 34 to 87 years of age (Table I). All of the fractures had been caused by accidents. Nine of the 10 patients had sustained the fracture in a low-velocity accident, and 1 patient (Case 9) had sustained the fracture as well as a brain injury as the result of a high-velocity (traffic) accident (see Appendix Table I). Seven of the 10 patients had a nosocomial infection, whereas 3 patients had contracted COVID-19 before admission to the hospital for the treatment of the fracture. The orthopaedic diagnosis was based on a radiograph or 3-dimensional CT scan (Fig. [1](#fig1){ref-type="fig"}). Nine of the 10 patients were exposed to SARS-CoV-2 either by contact with an infected individual or by direct exposure in a contagious environment. Three patients had osteoporosis along with an underlying disease such as hypertension, diabetes, and chronic obstructive pulmonary disease (COPD). Three patients (Cases 1, 4, and 7) did not exhibit severe symptoms or have obvious evidence of the disease on CT scans on admission and therefore underwent a surgical procedure; fever and fatigue signs were observed after the operation.

###### 

Clinical Characteristics of 10 Patients with Fracture[\*](#tblfn1){ref-type="table-fn"}

                                                             Case 1                                   Case 2                                   Case 3                                   Case 4                                   Case 5                                   Case 6                               Case 7                                   Case 8                                   Case 9                       Case 10                                  Total No. of Patients with Finding
  ---------------------------------------------------------- ---------------------------------------- ---------------------------------------- ---------------------------------------- ---------------------------------------- ---------------------------------------- ------------------------------------ ---------------------------------------- ---------------------------------------- ---------------------------- ---------------------------------------- ------------------------------------
  Clinical characteristics                                                                                                                                                                                                                                                                                                                                                                                                                                             
   Sex, age *(yr)*                                           F, 50                                    F, 34                                    F, 87                                    F, 79                                    F, 80                                    F, 84                                M, 76                                    F, 55                                    M, 85                        F, 54                                    ---
   Date of admission                                         Jan 2, 2020                              Jan 31, 2020                             Jan 13, 2020                             Jan 19, 2020                             Jan 20, 2020                             Jan 30, 2020                         Jan 17, 2020                             Feb 3, 2020                              Jan 16, 2020                 Feb 12, 2020                             ---
   Orthopaedic diagnosis                                     Intertrochanteric fracture               Femoral fracture                         Lumbar fracture                          Femoral neck fracture                    Intertrochanteric fracture               Intertrochanteric fracture           Intertrochanteric fracture               Fracture of radius                       Intertrochanteric fracture   Thoracolumbar fracture                   ---
   Epidemiological history                                   Yes (exposure to relevant environment)   Yes (exposure to relevant environment)   Yes (exposure to relevant environment)   Yes (exposure to relevant environment)   Yes (exposure to relevant environment)   Yes (contact with infected person)   Yes (exposure to relevant environment)   Yes (exposure to relevant environment)   No                           Yes (exposure to relevant environment)   9
   Complications                                             Hypertension, diabetes                   No                                       COPD, osteoporosis                       Osteoporosis                             Hypertension, diabetes, CAHD             Hypertension, osteoporosis           Cirrhosis, Alzheimer disease             No                                       Brain injury                 Hypertension, diabetes                   ---
   Orthopaedic operation                                     Jan 9, 2020                              No                                       No                                       Jan 21, 2020                             No                                       No                                   Jan 20, 2020                             No                                       No                           No                                       3
  Signs and symptoms                                                                                                                                                                                                                                                                                                                                                                                                                                                   
   Fever                                                     Yes                                      No                                       No                                       Yes                                      Yes                                      Yes                                  Yes                                      No                                       Yes                          Yes                                      7
   Cough                                                     Yes                                      No                                       No                                       Yes                                      Yes                                      Yes                                  Yes                                      Yes                                      Yes                          No                                       7
   Fatigue                                                   Yes                                      No                                       No                                       No                                       Yes                                      Yes                                  Yes                                      Yes                                      Yes                          Yes                                      7
   Sore throat                                               No                                       No                                       No                                       No                                       Yes                                      No                                   Yes                                      Yes                                      Yes                          No                                       4
   Dyspnea                                                   Yes                                      No                                       Yes                                      No                                       Yes                                      No                                   Yes                                      No                                       Yes                          No                                       5
   Chest pain                                                No                                       No                                       No                                       No                                       Yes                                      No                                   No                                       No                                       No                           No                                       1
   Nasal congestion                                          No                                       No                                       No                                       No                                       Yes                                      No                                   No                                       No                                       No                           No                                       1
   Headache                                                  No                                       No                                       No                                       No                                       Yes                                      No                                   No                                       No                                       No                           No                                       1
   Dizziness                                                 No                                       No                                       No                                       No                                       Yes                                      Yes                                  No                                       Yes                                      No                           No                                       3
   Diarrhea                                                  No                                       No                                       No                                       No                                       No                                       No                                   No                                       No                                       No                           No                                       0
   Abdominal pain                                            No                                       No                                       Yes                                      No                                       No                                       No                                   No                                       No                                       No                           No                                       1
   Vomiting                                                  No                                       No                                       Yes                                      No                                       No                                       No                                   No                                       No                                       No                           No                                       1
   Limited activity                                          Yes                                      Yes                                      Yes                                      Yes                                      Yes                                      Yes                                  Yes                                      Yes                                      Yes                          Yes                                      10
  Laboratory test results[†](#tblfn2){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                                                             
   White blood-cell count *(×10*^*9*^*/L)*                   13.45 (↑↑)                               4.93                                     21.9 (↑↑)                                12.37 (↑↑)                               6.43                                     6.95                                 9.6                                      4.23                                     11.27 (↑↑)                   5.21                                     4
   Neutrophil count *(×10*^*9*^*/L)*                         11.25 (↑↑)                               3.7                                      20.4 (↑↑)                                11.45 (↑↑)                               5.24                                     4.98                                 7.48                                     3.04                                     10.06 (↑↑)                   3.6                                      4
   Lymphocyte count *(×10*^*9*^*/L)*                         1.44                                     0.83 (↓↓)                                0.8 (↓↓)                                 0.59 (↓↓)                                0.47 (↓↓)                                1.11                                 1.48                                     0.93 (↓↓)                                0.46 (↓↓)                    1.09                                     6
   Monocyte count *(×10*^*9*^*/L)*                           0.58                                     0.33                                     0.8 (↑)                                  0.33                                     0.5                                      0.85 (↑)                             0.64 (↑)                                 0.24                                     0.72 (↑)                     0.33                                     4
   Platelet count *(×10*^*9*^*/L)*                           213                                      157                                      144                                      153                                      291                                      178                                  NA                                       189                                      106 (↓)                      167                                      1
   APTT *(s)*                                                146.7 (↑)                                26.4 (↓)                                 38.3                                     31.2                                     30.3                                     31.76                                32.2                                     29.8                                     35.5                         38.5                                     1, 1
   PT *(s)*                                                  75.9 (↑)                                 12.4                                     13.9                                     10.3 (↓)                                 12.2                                     12.95                                13.9                                     10.4 (↓)                                 13.4                         12.8                                     1, 2
   D-dimer *(mg/L)*                                          5.32 (↑)                                 NA                                       12.45 (↑)                                12.45 (↑)                                2.35 (↑)                                 5.23 (↑)                             1,622 (↑)                                1,155 (↑)                                17.02 (↑)                    6.73 (↑)                                 9
   Albumin *(g/L)*                                           28.7 (↓)                                 33.9 (↓)                                 34 (↓)                                   39.8                                     33.4 (↓)                                 33.8 (↓)                             28.4 (↓)                                 38.6                                     37.1                         40.6                                     6
   ALT *(U/L)*                                               0                                        20                                       15                                       15                                       10                                       42 (↑)                               15                                       5                                        18                           36 (↑)                                   2
   AST *(U/L)*                                               12                                       46 (↑)                                   35                                       29                                       21                                       64 (↑)                               38                                       20                                       27                           33                                       2
   Total bilirubin *(μmol/L)*                                7.7                                      9.1                                      18.8                                     6.8                                      9.2                                      14                                   41.8 (↑)                                 10                                       10.3                         18                                       1
   Blood urea nitrogen *(mmol/L)*                            13.44 (↑)                                5.43                                     18.8 (↑)                                 6.0                                      2.98                                     10.68 (↑)                            17.79 (↑)                                3.8                                      6.8                          3.19                                     4
   Creatinine *(μmol/L)*                                     419.3 (↑)                                42 (↓)                                   298 (↑)                                  42 (↓)                                   136 (↑)                                  104                                  78                                       37 (↓)                                   88                           55.5                                     3, 3
   Procalcitonin *(ng/mL)*                                   NA                                       0.009                                    19.05 (↑)                                0.219 (↑)                                0.15 (↑)                                 0.74 (↑)                             0.23 (↑)                                 NA                                       2.35 (↑)                     0.41 (↑)                                 7
   C-reactive protein *(mg/L)*                               156.9 (↑)                                6.8 (↑)                                  33 (↑)                                   96 (↑)                                   18.9 (↑)                                 14.5 (↑)                             NA                                       13.12 (↑)                                16.4 (↑)                     11.4 (↑)                                 9
  Evidence of COVID-19                                                                                                                                                                                                                                                                                                                                                                                                                                                 
   SARS-CoV-2 quantitative RT-PCR                            Negative                                 Negative                                 NA                                       Positive                                 Negative                                 Positive                             Positive                                 Positive                                 Positive                     Positive                                 6
   Typical signs of viral infection on CT                    Bilateral                                Unilateral                               Bilateral                                Bilateral                                Bilateral                                Bilateral                            Bilateral                                Bilateral                                Bilateral                    Bilateral                                10
  Treatment                                                                                                                                                                                                                                                                                                                                                                                                                                                            
   Oxygen inhalation                                         Yes                                      No                                       Yes                                      Yes                                      Yes                                      Yes                                  Yes                                      Yes                                      Yes                          Yes                                      9
   Antiviral therapy                                         Yes                                      Yes                                      Yes                                      Yes                                      Yes                                      Yes                                  Yes                                      Yes                                      Yes                          Yes                                      10
   Antibacterial therapy                                     Yes                                      Yes                                      Yes                                      Yes                                      Yes                                      Yes                                  Yes                                      Yes                                      Yes                          Yes                                      10
   Intravenous immunoglobulin therapy                        Yes                                      No                                       No                                       No                                       Yes                                      No                                   Yes                                      No                                       No                           No                                       3
   Glucocorticoid therapy                                    Yes                                      No                                       No                                       Yes                                      No                                       Yes                                  No                                       No                                       Yes                          No                                       4
   CKRT                                                      Yes                                      No                                       No                                       No                                       No                                       No                                   No                                       No                                       No                           No                                       1
   NIV                                                       No                                       No                                       Yes                                      No                                       Yes                                      No                                   Yes                                      No                                       No                           No                                       3
   IMV                                                       No                                       No                                       No                                       No                                       No                                       No                                   No                                       No                                       No                           No                                       0
   ECMO                                                      No                                       No                                       No                                       No                                       No                                       No                                   No                                       No                                       No                           No                                       0
  Co-infection                                               Coxsackie virus                          No                                       No                                       Epstein-Barr virus                       No                                       No                                   Candida                                  No                                       No                           No                                       3
  Clinical outcome                                           Remained in hospital                     Remained in hospital                     Died on Jan 21, 2020                     Remained in hospital                     Remained in hospital                     Died on Feb 7, 2020                  Died on Jan 31, 2020                     Remained in hospital                     Died on Jan 24, 2020         Remained in hospital                     

COPD = chronic obstructive pulmonary disease, CAHD = coronary atherosclerosis heart disease, CKRT = continuous kidney replacement therapy, NIV = noninvasive ventilation, IMV = invasive mechanical ventilation, ECMO = extracorporeal membrane oxygenation, NA = not available.

White blood-cell count: normal range, 3.5 to 9.5 × 10^9^/L, (↑↑) indicates leukocytosis (\>10.0 × 10^9^/L). Neutrophil count: normal range, 1.8 to 6.3 × 10^9^/L, (↑↑) indicates neutrophilic granulocytosis (\>7.5 × 10^9^/L). Lymphocyte count: normal range, 1.1 to 3.2 × 10^9^/L, (↓↓) indicates lymphopenia (\<1.0 × 10^9^/L). For the remaining laboratory values, the normal ranges are as follows: monocyte count, 0.1 to 0.6 × 10^9^/L; platelet count, 125 to 350 × 10^9^/L; APTT, 28.0 to 43.5 s; PT, 11.0 to 16.0 s; D-dimer, \<0.5 mg/L FEU (fibrinogen equivalent units); albumin, 35 to 55 g/L; alanine aminotransferase (ALT), 5 to 35 U/L; aspartate aminotransferase (AST), 8 to 40 U/L; total bilirubin, 5.1 to 19.0 μmol/L; blood urea nitrogen, 2.9 to 8.2 mmol/L; creatinine, 44.0 to 106.0 μmol/L; procalcitonin, \<0.05 ng/mL; C-reactive protein, 0 to 5 mg/L. For those values, (↑) or (↓) indicates an increase or decrease compared with the normal level.

![**Figs. 1-A through 1-J** CT scans and radiographs showing the fractures in the present study. **Fig. 1-A** Case 1. Preoperative CT scan showing an intertrochanteric fracture and postoperative radiograph. **Fig. 1-B** Case 2. Preoperative radiograph showing a femoral fracture. **Fig. 1-C** Case 3. Preoperative CT scan showing a lumbar fracture. **Fig. 1-D** Case 4. Preoperative and postoperative radiographs for a patient with a femoral neck fracture. **Fig. 1-E** Case 5. Preoperative radiograph showing an intertrochanteric fracture. **Fig. 1-F** Case 6. Preoperative CT scan showing an intertrochanteric fracture. **Fig. 1-G** Case 7. Preoperative and postoperative radiographs for a patient with an intertrochanteric fracture. **Fig. 1-H** Case 8. Preoperative CT scan showing a fracture of the radius. **Fig. 1-I** Case 9. Preoperative radiograph showing an intertrochanteric fracture. **Fig. 1-J** Case 10. Preoperative CT scan showing a thoracolumbar fracture.](jbjsam-102-750-g001){#fig1}

Given the presence of fracture, all patients had limited function on the injured side. Seven patients each (70%) reported fever, cough, and fatigue; 4 (40%) had a sore throat; 5 (50%) presented with dyspnea; and 3 (30%) had dizziness. One patient (Case 5) (10%) reported chest pain, nasal congestion, and headache, and 1 patient (Case 3) (10%) reported abdominal pain and vomiting. No patient presented with diarrhea.

The results of laboratory tests are also shown in Table I. Four patients had leukocytosis (\>10.0 × 10^9^ cells/L), and 6 had lymphopenia (\<1.0 × 10^9^ cells/L). Additionally, 4 patients had neutrophilic granulocytosis (\>7.5 × 10^9^ cells/L) and 4 patients had an increased count of monocytes (\>0.6 × 10^9^ cells/L). Blood coagulation assays showed normal activated partial thromboplastin time (APTT) in 8 patients (80%) and normal prothrombin time (PT) in 7 patients (70%). However, because of limited activity, 9 (100%) of 9 patients had an abnormal level of D-dimer, which reached 1,155 mg/L in 1 case. Six (60%) of 10 patients had a low level of albumin because of their poor condition. Most patients had normal levels of alanine aminotransferase (ALT) (8 patients; 80%), aspartate aminotransferase (AST) (8 patients; 80%), total bilirubin (9 patients; 90%), and blood urea nitrogen (6 patients; 60%). The level of creatinine was higher than normal in 3 patients and lower than normal in 3 patients. Seven (88%) of 8 patients had an elevated procalcitonin concentration, and 9 (100%) of 9 patients had a high level of C-reactive protein. While only 6 patients (60%) tested positive for SARS-CoV-2, CT imaging demonstrated unilateral or bilateral patchy consolidation or ground-glass opacities in all patients (Fig. [2](#fig2){ref-type="fig"}). Therefore, according to the New Coronavirus Pneumonia Prevention and Control Program (6th edition), all patients were considered or highly suspected to have COVID-19. The timing of typical signs of viral infection on CT scans (discrete ground-glass opacities in specific areas of the lung) and the timing of relevant positive SARS-CoV-2 qRT-PCR tests are listed in Appendix Table I. The detailed changes in routine blood test results, coagulation function, blood biochemistry, and infection-related biomarkers were collected starting from the date of admission (Figs. [3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}).

![**Figs. 2-A through 2-J** Chest CT scans for all 10 patients. All patients but 1 had bilateral patchy consolidation and multiple ground-glass opacities. The remaining patient (Case 2) had ground-glass opacities on the right side. **Fig. 2-A** Case 1. **Fig. 2-B** Case 2. **Fig. 2-C** Case 3. **Fig. 2-D** Case 4. **Fig. 2-E** Case 5. **Fig. 2-F** Case 6. **Fig. 2-G** Case 7. **Fig. 2-H** Case 8. **Fig. 2-I** Case 9. **Fig. 2-J** Case 10.](jbjsam-102-750-g002){#fig2}

![Line graphs illustrating detailed changes in routine blood test results and coagulation function for all 10 patients, starting on the day of disease onset (Case 1) or the day of admission (Cases 2 through 9). The normal ranges of laboratory test results are as follows: white blood-cell count, 3.5 to 9.5 × 10^9^/L; neutrophil count, 1.8 to 6.3 × 10^9^/L; lymphocyte count, 1.1 to 3.2 × 10^9^/L; monocyte count, 0.1 to 0.6 × 10^9^/L; platelet count, 125 to 350 × 10^9^/L; hemoglobin, 115 to 150 g/L; APTT, 28.0 to 43.5 s; PT, 11.0 to 16.0 s; D-dimer, \<0.5 mg/L FEU (fibrinogen equivalent units).](jbjsam-102-750-g003){#fig3}

![Line graphs showing detailed changes of blood biochemistry and infection-related biomarkers for all 10 patients, starting from disease onset (Case 1) or the day of admission (Cases 2 through 9). The normal ranges of laboratory test results are as follows: albumin, 35 to 55 g/L; alanine aminotransferase (ALT), 5 to 35 U/L; aspartate aminotransferase (AST), 8 to 40 U/L; total bilirubin, 5.1 to 19.0 μmol/L; blood urea nitrogen, 2.9 to 8.2 mmol/L; creatinine, 44.0 to 106.0 μmol/L; procalcitonin, \<0.05 ng/mL; C-reactive protein, 0 to 5 mg/L.](jbjsam-102-750-g004){#fig4}

Nine (90%) of the 10 patients were managed with supplemental oxygen. All patients received antiviral therapy (oseltamivir) and antibacterial therapy (moxifloxacin). Additionally, 3 patients (30%) were managed with intravenous immunoglobulin, 3 patients were subjected to noninvasive ventilation, and 4 patients (40%) received glucocorticoids. One patient (Case 1) was managed with continuous kidney replacement therapy as she was diagnosed with decompensation of diabetic nephropathy during hospitalization. Because of the local limitations in medical technology and sudden worsening of the condition, invasive mechanical ventilation and extracorporeal membrane oxygenation were not utilized in these cases. Four patients (Cases 3, 6, 7, and 9) died on days 8, 8, 14, and 8, respectively, after admission. The remaining 6 patients remained in the hospital for further treatment. The clinical outcomes for surviving patients are not yet determined.

Discussion
==========

The current study presents the clinical data for 10 patients with a fracture who were diagnosed with COVID-19 pneumonia. Previous investigations have documented that the clinical characteristics of patients with both a fracture and pneumonia were more serious than those of patients with only a fracture. As of February 27, 2020, of the 10 patients in the current analysis, 4 patients (Cases 3, 6, 7, and 9) had died and 3 others (Cases 1, 4, and 5) had developed severe pneumonia. These findings indicate that the development of COVID-19 pneumonia in patients with fracture can lead to severe adverse outcomes and increase mortality.

Patients with open fractures or severe injuries who are admitted to the orthopaedic trauma department require emergency surgery^[@bib13],[@bib14]^. At the same time, most patients with hip fracture are older, many are in relatively poor physical condition, and many have underlying diseases such as hypertension, diabetes, or heart disease^[@bib15],[@bib16]^. Such patients generally are advised to undergo surgical treatment as soon as possible. This approach not only promotes fracture-healing and facilitates recovery of mobility but also reduces various complications, such as the onset of pneumonia and deep-vein thrombosis^[@bib17]^. If surgical treatment is not possible, these patients must remain in bed for 8 to 12 weeks, and, because of pain and the use of traction, most have to lie flat without being able to roll over, let alone stand. The stress associated with the fracture and surgical treatment can trigger a series of oxidative stress responses and excessive inflammation^[@bib18]^. These reactions upregulate the expression of a series of inflammatory factors and decrease the immunity of the patients, increasing the likelihood of pneumonia^[@bib19]^. Postoperative pulmonary complications have been reported to occur in 4.9% of patients after the surgical treatment of a hip fracture^[@bib20]^. Wong et al. reported the case of an 81-year-old woman with an intertrochanteric fracture and SARS who died 7 days after surgery^[@bib21]^. In the present study, 1 patient (Case 7) died 11 days after surgery and 3 patients (Cases 3, 6, and 9) died 8 days after admission without surgery being performed. Considering the high mortality of patients with COVID-19, surgical treatment for patients with both a fracture and COVID-19 should be carefully planned in advance. Furthermore, particular attention should be given to such patients after the surgical treatment of the fracture because of possibility of rapid deterioration of their condition.

In the present study, the common symptoms of patients with a fracture and COVID-19 pneumonia were similar to those in patients with COVID-19 but without a fracture. Laboratory tests suggested that lymphopenia was more likely to occur in patients with a fracture. Additionally, compared with the data in published articles on COVID-19, the median neutrophil count and D-dimer were higher than the upper normal limits of the corresponding indicators, which could represent the special laboratory characteristics of fractures in patients with COVID-19 (see Appendix Table II). qRT-PCR demonstrated that 3 patients (Cases 1, 2, and 5) were negative for the COVID-19 nucleic acid, whereas CT scans of the chest showed typical images of viral infection in all patients.

The present study documented that patients with a fracture may be at a higher risk of COVID-19 pneumonia. Seven of the 10 patients had a nosocomial infection. It is therefore essential to adopt strict infection-control measures. SARS-CoV-2 is thought to be transmitted directly by contact or by aerosol. Doctors, nurses, patients, and families should be wearing protective devices such as an N95 respirator and goggles.

On the basis of the current investigation, 4 major strategies for patients with a fracture and COVID-19 pneumonia can be proposed. First, nonoperative treatment should be considered for older patients with fractures, such as distal radial fractures, in endemic areas. Second, strict infection-control measures should be implemented for patients with fractures, particularly those undergoing surgical treatment. Third, patients with a fracture and COVID-19 pneumonia should be given more intensive surveillance and treatment. Fourth, surgical treatment for patients with a fracture and COVID-19 pneumonia should be performed in a negative-pressure operating room.

In summary, the symptoms of patients with a fracture with COVID-19 disease were diverse, with cough, fatigue, and fever being the main signs. Older patients with a hip fracture are at a higher risk of death. Future studies on the clinical characteristics of patients who have both a fracture and COVID-19 are essential to provide guidance for treatment in these rare cases.

Appendix
========

Supporting material provided by the authors is posted with the online version of this article as a data supplement at [jbjs.org](http://jbjs.org) (<http://links.lww.com/JBJS/F821>).
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